4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000163
Chairperson & CEO sold 9,500 shares at an average $545.52 ($5,182,414)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
11 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-13 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-10-13 | Sale : show line 2 in the form 10b5-1 | −639 | $542.76 | $346,822 | 333,304 | I |
| 2026-10-13 | Sale : show line 3 in the form 10b5-1 | −2,340 | $543.48 | $1,271,750 | 330,964 | I |
| 2026-10-13 | Sale : show line 4 in the form 10b5-1 | −1,492 | $544.56 | $812,483 | 329,472 | I |
| 2026-10-13 | Sale : show line 5 in the form 10b5-1 | −1,507 | $545.52 | $822,102 | 327,965 | I |
| 2026-10-13 | Sale : show line 6 in the form 10b5-1 | −1,452 | $546.46 | $793,459 | 326,513 | I |
| 2026-10-13 | Sale : show line 7 in the form 10b5-1 | −630 | $547.47 | $344,908 | 325,883 | I |
| 2026-10-13 | Sale : show line 8 in the form 10b5-1 | −698 | $548.49 | $382,844 | 325,185 | I |
| Open-market sales · 9,500 sh · avg $545.52 · $5,182,414 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-13 | Exercise or conversion : show line 12 in the form 10b5-1 Stock Option | −9,500 | 242,910 | I |
Loading xslF345X06/primarydocument.xml…